COT/COM/COC Annual Report Index

E - Index

Last updated: 11 January 2024

Subject:

ECETOC

Year

Page

Monograph on Aneuploidy

1997

78

workshop on use of T25 in chemical carcinogen evaluation

2001

141

Subject:

Electronic nicotine, or non-nicotine, delivery s ystems (e-cigarettes), potential toxicological risks from

Year

Page

Aerosol particle fraction, characterisation of

2017

28

Carcinogenicity data, overview of available

2018

50

Exposure to EN(N)DS aerosols, metals and solvents, silicon/silicate particles, nicotine toxicity

2018

28

Exposure to EN(N)DS aerosols - known constituents and potential adverse health outcomes arising from

2020

9

Flavouring compounds, framework for risk assessment of

2019

18

Genotoxic risk, potential

2018

43

Nicotine salts in, a summary of data published to date

2020

34

Statement on,

2020

6

Toxicological risks, potential

2019

52

Addendum to the statement on

2021

26

Subject:

Endocrine disrupting chemicals

Year

Page

Definition for regulatory purposes

2010

11

Risk assessment of

2019

17

Subject:

Endosulfan

Year

Page

Endosulfan, pentachlorobenzene and chlordecone in the infant diet

2013

18

Subject:

Energy drinks

Year

Page

in the diet of children and adolescents, final statement on

2019

10

interim statement on

2018

29

Subject:

  Enrofloxacin (veterinary medicine)

Year

Page

carcinogenicity in laboratory rodents

1993

50

in vitro and in vivo carcinogenicity

1992

56

Subject:

Environmental Tobacco Smoke (ETS) and lung cancer

Year

Page

COC statement on

1997

88

consideration of paper by Enstrom JE and Kabat GC (2003). British Medical Journal volume 326, 1057-1066

2003

191

Subject:

Environmental mutagens

Year

Page

Significance of environmental mutagenesis

2004

141

Subjects:

Enzymes

Year

Page

Amano 90 – submission to COT

2000

15

Enzyme submission COT

2001

9

Chymosin – Enzyme submission COT

1999

16

Enzyme submission COT, modified recovery and purification

2000

16

Enzyme submission –derived from GM aspergillus niger var. awamori

2002

10

Enzyme submission –derived from GM Aspergillus niger var. awamori

2003

8

Hemicellulase Enzyme in bread-making

1999

19

Immobilised lipase from Rhizopus niveus COT consideration of the safety-in-use of

1994

9

COT consideration of additional data for

1998

13

Lipase D  Enzyme submission COT

2000

16

Enzyme submission COT

2001

9

Newlase analytical method to detect rhizoxin

2000

17

Enzyme submission COT update, method review

2002

11

Enzyme submission COT,

2004

10

Enzyme Submission – Newlase analytical method to detect

rhizoxin

2004

10

Xylanase preparation from Aspergillus niger

2001

13

Microbial enzyme preparations (safety assessment of)

1991

17

Subject:

Eosinophilia-myalgia syndrome, tryptophan and

Year

Page

risk to health of tryptophan, particularly in food supplements.

2003

21, 83

COT review of a contaminant in the tryptophan produced by one manufacturer

2004

12

Subject:

Epigenetics in carcinogenesis

Year

Page

COC evaluation of

2013

53

COC evaluation of

2016

35

in chemical risk assessment,

2017

54

in chemical risk assessment,

2017

43

joint committee workshop on

2018

42

Subject:

Epoxidised soya bean oil

Year

Page

COT evaluation of; TDI

1994

8

COT evaluation of; updated guidance from 1994 report

1999

16

Subject:

Erythritol

Year

Page

laxation

2003

9

sensitivity of young children to polyols

2004

9

Subject:

Erythrosine

Year

Page

COT review of

1991

29

Subject:

Ethaboxam

Year

Page

partial COM review of

2007

131

Subject:

Ethanol (see also alcohol)

Year

Page

acetaldehyde and alcoholic beverages

2000

62

effects on pregnancy, reproduction and infant

development

1995

8

Subject:

Exhaust, diesel

Year

Page

Carcinogenicity of

1991

47

Subject:

Exposure Assessment

Year

Page

Food chemicals, to

2002

12

Less than lifetime

2020

31

Statement on assessment of less than lifetime exposure

2021

19

single or short term, to carcinogens

2005

140

Draft EFSA Scientific Committee Opinion on scientific criteria for grouping chemicals into assessment groups for human risk assessment of combined exposure to multiple chemicals 

2021

26